New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Merck KGaA
www.emdgroup.com/en
Latest From Merck KGaA
Novartis Upbeat As Ofatumumab Data Delivers In MS
Novartis looks to differentiate ofatumumab from Roche's entrenched MS blockbuster Ocrevus, stressing that patients can inject the therapy at home.
Keeping Track: US FDA Approvals For Ibsrela, Gvoke And Nucala; A BTD For Tepotinib
The latest drug development news and highlights from our US FDA Performance Tracker.
Merck KGaA Says New Meds Will Add €2bn Sales
The German group believes its €2bn target of pipeline sales by 2022 is achievable. It is hoping for a healthy contribution from rare lung cancer drug tepotinib.
GSK Buys One Of Eight Firms Formed In VC Partnership With Avalon
Celiac disease specialist Sitari was the first company formed under the six-year collaboration. Three were shut down and Avalon controls the other four, which aren't compatible with GSK's new R&D focus.
Company Information
- Industry
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Cardiovascular
- Gynecological, Urological
- Metabolic Disorders
- Neurology, Nervous System
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
Germany
-
Germany
-
Western Europe
-
Europe
- Company Type
- Midsize European
- Parent & Subsidiaries
-
Merck KGaA
- Amerpharm Investments Ltd.
- Biovation Ltd.
- Center Laboratories
- Chemische Fabrik Lehrte Dr. Andreas Kossel
- Durachemie GMBH
- E. Merck Nederland
- EM Laboratories Inc
- EM Pharmaceuticals Inc.
- EMD Biosciences Inc.
- EMD Chemicals Inc.
- EMD Lexigen Research Center
- EMD Serono Inc.
- Genpharm Inc.
- Hermal Kurt Herrmann & Co.
- Hermal Pharmaceutical Laboratories Inc.
- Laboratoire Theramex
- Laboratoires Merck-Clevenot SA
- Laboratorios BOI SA
- Lipha Chemicals Inc.
- Lipha Pharmaceuticals Inc.
- Lipha SA
- Merck Eprova AG
- Merck Ethicals
- Merck HOEI
- Merck Lipha
- Merck Pharma SPA
- Merck Pty. Ltd.
- Merck SA Industrias Quimicas
- Merck Sante SAS
- Merck Serono SA
- MilliporeSigma
- NM Pharma AS
- Novagen Inc.
- VWR Canlab
- Senior Management
-
Stefan Oschmann, PhD, CEO
Marcus Kuhnert, CFO - Contact Info
-
Merck KGaA
Phone: (49) 6151 72 0
Frankfurter Str. 250
Darmstadt, MA 64293
Germany
Advertisement
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Merck KGaA
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice